<DOC>
	<DOCNO>NCT02510482</DOCNO>
	<brief_summary>Calcified aortic valve stenosis ( CAVS ) progressive disease nowadays , cornerstone diagnostics follow-up echocardiography . Cardiac biomarkers ( cardiac troponins T I NT-pro-BNP ) hold promise fulfil role early recognition complication concern aortic valve decompensation . For purpose , important ass normal biological variation ( BV ) cardiac biomarkers CAVS . The assessment biological variation contribute well understanding fluctuation cardiac biomarkers subject stable CAVS . These data improve monitoring CAVS use cardiac biomarkers .</brief_summary>
	<brief_title>Biological Variation Cardiac Biomarkers Aortic Valve Stenosis</brief_title>
	<detailed_description />
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Aortic Valve Stenosis</mesh_term>
	<criteria>Clinically stable moderate aortic valve stenosis No evidence acute cardiovascular disease Acute myocardial infarction last six month Pulmonary embolism last six month Hospitalisation heart failure last six month Chronic kidney disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>cardiac biomarkers</keyword>
</DOC>